REVIEW
Accepted on 21 Apr 2025
Translational Insights from EAE Models：Decoding MOGAD Pathogenesis and Therapeutic Innovation
doi 10.3389/fimmu.2025.1530977
- Frontiers in Neurology
- Multiple Sclerosis and Neuroimmunology
- Research Topics
- Monoclonal antibodies in treating multiple sclerosis (MS), and related diseases.
Monoclonal antibodies in treating multiple sclerosis (MS), and related diseases.
3,901
Total downloads
14k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
CASE REPORT
Published on 04 Apr 2025
Switching to ublituximab from prior anti-CD20 monoclonal antibody therapy: a case report series
doi 10.3389/fimmu.2025.1527102
- 1,875 views
ORIGINAL RESEARCH
Accepted on 02 Apr 2025
Immunotherapy for Neuromyelitis Optica Spectrum Disorder: A Comparative Analysis of Efficacy and Safety of Azathioprine, Mycophenolate Mofetil, Tacrolimus, and Rituximab
doi 10.3389/fneur.2025.1559118
- 117 views
CASE REPORT
Published on 17 Jan 2025
Severe Guillain-Barré syndrome with concurrent optic neuritis in a pediatric patient: a case report
doi 10.3389/fimmu.2024.1517943
- 780 views
- 1 citation
ORIGINAL RESEARCH
Published on 06 Jan 2025
Clinical and analytical monitoring of patients with multiple sclerosis on anti-CD20 therapeutics: a real-world safety profile study
doi 10.3389/fneur.2024.1500763
- 1,351 views
ORIGINAL RESEARCH
Published on 12 Nov 2024
Biomarkers of response to ocrelizumab in relapsing–remitting multiple sclerosis
doi 10.3389/fimmu.2024.1480676
- 1,667 views
ORIGINAL RESEARCH
Published on 06 Nov 2024
A comparison of natalizumab’s effects on SDMT between pediatric-onset and adult-onset multiple sclerosis patients
doi 10.3389/fneur.2024.1475161
- 617 views
ORIGINAL RESEARCH
Published on 24 Oct 2024
Improvements in no evidence of disease activity with ublituximab vs. teriflunomide in the ULTIMATE phase 3 studies in relapsing multiple sclerosis
doi 10.3389/fneur.2024.1473284
- 1,604 views
ORIGINAL RESEARCH
Published on 15 Jul 2024
Hyper-reflective foci changes in RRMS under natalizumab therapy
doi 10.3389/fimmu.2024.1421755
- 856 views
- 1 citation
ORIGINAL RESEARCH
Published on 12 Jun 2024
Abnormal brain spontaneous neural activity in neuromyelitis optica spectrum disorder with neuropathic pain
doi 10.3389/fneur.2024.1408759
- 840 views
CASE REPORT
Published on 05 Jun 2024
A case report of AQP4-IgG-seropositive refractory neuromyelitis optica spectrum disorder patient with Sjögren’s syndrome and pancytopenia treated with inebilizumab
doi 10.3389/fneur.2024.1371515
- 1,086 views
Published in
Frontiers in Neurology
Multiple Sclerosis and Neuroimmunology
Participating Journals
Frontiers in Immunology
- 5.7 impact factor
- 9.8 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: